Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35661166

Teclistamab in Relapsed or Refractory Multiple Myeloma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2022 Aug 11
First author
Moreau P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2022 Aug 11;387(6):558-561. doi: 10.1056/NEJMe2209692.
    note
    Source null
    related pmid
    35947712
    relationship
    Comment in
  2. citation
    N Engl J Med. 2022 Nov 3;387(18):1721. doi: 10.1056/NEJMc2211969.
    note
    Source null
    related pmid
    36322859
    relationship
    Comment in
  3. citation
    N Engl J Med. 2022 Nov 3;387(18):1721-1722. doi: 10.1056/NEJMc2211969.
    note
    Source null
    related pmid
    36322860
    relationship
    Comment in

Authors and identifiers

  1. name
    Moreau P
    type
    Author
  2. name
    Garfall AL
    type
    Author
  3. name
    van de Donk NWCJ
    type
    Author
  4. name
    Nahi H
    type
    Author
  5. name
    San-Miguel JF
    type
    Author
  6. name
    Oriol A
    type
    Author
  7. name
    Nooka AK
    type
    Author
  8. name
    Martin T
    type
    Author
  9. name
    Rosinol L
    type
    Author
  10. name
    Chari A
    type
    Author
  11. name
    Karlin L
    type
    Author
  12. name
    Benboubker L
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Moreau P
    type
    Author
  2. name
    Garfall AL
    type
    Author
  3. name
    van de Donk NWCJ
    type
    Author
  4. name
    Nahi H
    type
    Author
  5. name
    San-Miguel JF
    type
    Author
  6. name
    Oriol A
    type
    Author
  7. name
    Nooka AK
    type
    Author
  8. name
    Martin T
    type
    Author
  9. name
    Rosinol L
    type
    Author
  10. name
    Chari A
    type
    Author
  11. name
    Karlin L
    type
    Author
  12. name
    Benboubker L
    type
    Author
bibliography ids
  1. nci-bib-ffe30a1d4e281f760e74a190
book metadata
content sha256
a5c2781fe3ebb81a07c7b33ea541203d596cfed8034729e315e4eda426c9d477
document type
citation
dois
  1. 10.1056/NEJMoa2203478
electronic publication date
display
2022 Jun 5
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:35661166
immutable id
pubmed:35661166@a5c2781fe3ebb81a07c7b33ea541203d596cfed8034729e315e4eda426c9d477
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
6
name
The New England journal of medicine
nlm unique id
0255562
pages
495-505
volume
387
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2022 Aug 11;387(6):558-561. doi: 10.1056/NEJMe2209692.
    note
    Source null
    related pmid
    35947712
    relationship
    Comment in
  2. citation
    N Engl J Med. 2022 Nov 3;387(18):1721. doi: 10.1056/NEJMc2211969.
    note
    Source null
    related pmid
    36322859
    relationship
    Comment in
  3. citation
    N Engl J Med. 2022 Nov 3;387(18):1721-1722. doi: 10.1056/NEJMc2211969.
    note
    Source null
    related pmid
    36322860
    relationship
    Comment in
outcomes validated
false
pmid
35661166
provenance
batch id
9d150d55960e0c12aada
provider
NCBI PubMed ESummary
record sha256
8ba968c6af49cf0d8f9349e6ab3050f96cfc54ed9c22a0db1df8f70ffeb788e2
response sha256
2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
retrieved at
2026-09-09T23:48:09.820498+00:00
publication date
display
2022 Aug 11
precision
day
year
2022
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/35661166/
title
Teclistamab in Relapsed or Refractory Multiple Myeloma.

Preserved source evidence · Not medical advice